17:23 IST
NSE
Business Update
Natco Pharma Business Update
Natco Pharma concluded a US FDA inspection at its Visakhapatnam FDF unit. The inspection resulted in 4 procedural observations, which the company intends to address.
Natco Pharma Ltd
- Share price
- ₹810.10
- Market cap
- ₹15,892 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.9×Sector 47.3×
- Promoter holding
- 49.42%+0.00% QoQ
- FII holding
- 16.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Board Meeting Date 4Financial Results 3Capital Structure Change 3Board Meeting Outcome 3Regulatory Approval 2Other Announcement 2Legal & Regulatory 2Fund Raise 2Acquisition 2Promoter Selling (Off-Market) 1Merger & Restructuring 1Management Change 1Dividend 1Business Update 1Annual Report 1Annual General Meeting 1
Time
1 announcement with these filters